For a patient with Enterococcus faecalis infection susceptible to ampicillin, ciprofloxacin, and nitrofurantoin, but allergic to ciprofloxacin and nitrofurantoin, what oral antibiotic alternatives are appropriate when IV therapy cannot be used?

Oral Ampicillin is Your Best Option

For ampicillin-susceptible Enterococcus faecalis with allergies to ciprofloxacin and nitrofurantoin, oral ampicillin is the definitive first-line oral therapy when IV antibiotics cannot be administered. 1

Treatment Recommendation

Primary Choice: Oral Ampicillin

• Dosing: 500 mg orally every 6 hours (or up to 18-30 g daily in divided doses for serious infections like UTI with high MIC) 2
• Administration: Take with a full glass of water, 30 minutes before or 2 hours after meals 1
• Duration: Minimum 10 days for most infections; longer for complicated cases 1

Why Ampicillin Works Here

The organism is susceptible to ampicillin, making this the natural choice. The FDA label explicitly indicates ampicillin for E. faecalis infections of the genitourinary and gastrointestinal tracts 1. Even for ampicillin-resistant enterococci, high urinary concentrations can overcome resistance in UTIs, with clinical cure rates of 88.1% 2. Since your isolate is susceptible, outcomes should be excellent.

Alternative Oral Options (If Ampicillin Fails or Is Not Tolerated)

Second-Line Choices:

1. Amoxicillin (500 mg PO every 8 hours)

   • Essentially equivalent to ampicillin for enterococcal infections 2
   • Better absorbed orally, can be taken with food
   • Recommended specifically for uncomplicated UTIs due to VRE 2

2. Amoxicillin-Clavulanate

   • 100% susceptibility demonstrated in periodontal E. faecalis isolates 3
   • Provides additional coverage if polymicrobial infection suspected
   • Recommended for mild-to-moderate intra-abdominal infections 4

3. Fosfomycin (3 g single oral dose)

   • FDA-approved for E. faecalis UTI 2
   • 86% susceptibility for vancomycin-resistant E. faecalis 5
   • Only for uncomplicated cystitis, not systemic infections 2

Critical Caveats

What NOT to Use:

• Tetracycline/Doxycycline: 53.2% resistance in E. faecalis 3
• Erythromycin: 80.8% resistant or intermediate 3
• Clindamycin: 100% resistance 3
• Metronidazole: 100% resistance 3
• Cephalosporins alone: Enterococci have intrinsic resistance due to low-affinity penicillin-binding proteins 6

Important Monitoring:

• Diabetic patients: Ampicillin can cause false-positive urine glucose with copper sulfate tests (Benedict's, Fehling's, Clinitest) but NOT with enzyme-based tests (Clinistix, Tes-Tape) 1
• Prolonged therapy: Monitor renal, hepatic, and hematopoietic function periodically 1
• Superinfection risk: Watch for fungal overgrowth with extended courses 1

Drug Interactions to Avoid:

• Allopurinol: Increases skin rash risk 1
• Bacteriostatic antibiotics (chloramphenicol, erythromycins, tetracyclines): May interfere with ampicillin's bactericidal effect 1
• Oral contraceptives: May be less effective with ampicillin 1

Site-Specific Considerations

If this is a UTI: Ampicillin, amoxicillin, or fosfomycin (for simple cystitis only) are all excellent choices 2, 5, 7

If this is bacteremia or endocarditis: Oral therapy is generally inadequate—you need IV ampicillin ideally combined with gentamicin or ceftriaxone 6, 8. If truly unable to provide IV access, this represents a medical emergency requiring hospitalization for central line placement.

If this is intra-abdominal infection: Ampicillin plus metronidazole or amoxicillin-clavulanate for mild-to-moderate cases 4

Bottom Line Algorithm

1. Confirm infection site and severity (not just colonization)
2. If uncomplicated UTI: Oral ampicillin 500 mg q6h OR amoxicillin 500 mg q8h OR fosfomycin 3g single dose
3. If complicated UTI or other site: Oral ampicillin 500 mg q6h (higher doses may be needed)
4. If ampicillin intolerance develops: Switch to amoxicillin or amoxicillin-clavulanate
5. If severe infection: Reconsider IV access—oral therapy may be insufficient for serious enterococcal infections

The susceptibility pattern you have is favorable, and oral ampicillin should provide excellent clinical outcomes for most non-severe enterococcal infections 1, 5.